{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:00:27Z","timestamp":1792814427364,"version":"4.5.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>CD4+ T cells may induce potent antitumor immune responses through interaction with antigen-presenting cells within the tumor microenvironment. Using a murine model of multiple myeloma, we demonstrated that adoptive transfer of idiotype-specific CD4+ T cells may elicit curative responses against established multifocal myeloma in bone marrow. This finding indicates that the myeloma bone marrow niche contains antigen-presenting cells that may be rendered tumoricidal. Given the complexity of the bone marrow microenvironment, the mechanistic basis of such immunotherapeutic responses is not known. Through a functional characterization of antitumor CD4+ T-cell responses within the bone marrow microenvironment, we found that killing of myeloma cells is orchestrated by a population of bone marrow\u2013resident CD11b+F4\/80+MHC-IIHigh macrophages that have taken up and present secreted myeloma protein. The present results demonstrate the potential of resident macrophages as powerful mediators of tumor killing within the bone marrow and provide a basis for novel therapeutic strategies against multiple myeloma and other malignancies that affect the bone marrow.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001434","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:18:20Z","timestamp":1592331500000},"page":"2595-2605","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":27,"title":["CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-9250","authenticated-orcid":false,"given":"Ole Audun W.","family":"Haabeth","sequence":"first","affiliation":[{"name":"Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway;"},{"name":"Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjartan","family":"Hennig","sequence":"first","affiliation":[{"name":"Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte","family":"Fauskanger","sequence":"first","affiliation":[{"name":"Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway;"},{"name":"K. G. Jebsen Centre for B cell Malignancies, Oslo University Hospital, Rikshospitalet, Oslo, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-8571","authenticated-orcid":false,"given":"Geir \u00c5ge","family":"L\u00f8set","sequence":"first","affiliation":[{"name":"Department of Biosciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Bogen","sequence":"first","affiliation":[{"name":"Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway;"},{"name":"K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0668-9262","authenticated-orcid":false,"given":"Anders","family":"Tveita","sequence":"first","affiliation":[{"name":"Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway;"},{"name":"K. G. Jebsen Centre for B cell Malignancies, Oslo University Hospital, Rikshospitalet, Oslo, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"issue":"7549","key":"2020062311293582000_B1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer [published correction appears in Nature. 2015;523:370]","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"issue":"7662","key":"2020062311293582000_B2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma [published correction appears in Nature. 2018;555:402]","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"6184","key":"2020062311293582000_B3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"issue":"17","key":"2020062311293582000_B4","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1158\/1078-0432.CCR-15-0233","article-title":"Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival","volume":"21","author":"Reed","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2020062311293582000_B5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/eji.1830150313","article-title":"T helper cell recognition of idiotopes on \u03bb 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region","volume":"15","author":"Bogen","year":"1985","journal-title":"Eur J Immunol"},{"issue":"1","key":"2020062311293582000_B6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.86.1.282","article-title":"B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells","volume":"86","author":"Weiss","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2020062311293582000_B7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0092-8674(91)90506-T","article-title":"MHC class II-restricted presentation of intracellular antigen","volume":"64","author":"Weiss","year":"1991","journal-title":"Cell"},{"issue":"1","key":"2020062311293582000_B8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.178.1.27","article-title":"Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles","volume":"178","author":"Chicz","year":"1993","journal-title":"J Exp Med"},{"issue":"6345","key":"2020062311293582000_B9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/353622a0","article-title":"Sequence analysis of peptides bound to MHC class II molecules","volume":"353","author":"Rudensky","year":"1991","journal-title":"Nature"},{"issue":"7647","key":"2020062311293582000_B10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nature21433","article-title":"Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens","volume":"543","author":"Khodadoust","year":"2017","journal-title":"Nature"},{"issue":"11","key":"2020062311293582000_B11","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1084\/jem.20092450","article-title":"Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase","volume":"207","author":"Schietinger","year":"2010","journal-title":"J Exp Med"},{"issue":"3","key":"2020062311293582000_B12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20091918","article-title":"Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts","volume":"207","author":"Quezada","year":"2010","journal-title":"J Exp Med"},{"issue":"2","key":"2020062311293582000_B13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1182\/blood-2002-11-3381","article-title":"Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies","volume":"102","author":"Lundin","year":"2003","journal-title":"Blood"},{"issue":"3","key":"2020062311293582000_B14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"Corthay","year":"2005","journal-title":"Immunity"},{"issue":"12","key":"2020062311293582000_B15","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","article-title":"CD4 cells can be more efficient at tumor rejection than CD8 cells","volume":"109","author":"Perez-Diez","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2020062311293582000_B16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(00)80218-6","article-title":"CD4+ T cell\u2013mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells","volume":"12","author":"Qin","year":"2000","journal-title":"Immunity"},{"issue":"12","key":"2020062311293582000_B17","doi-asserted-by":"crossref","first-page":"e51892","DOI":"10.1371\/journal.pone.0051892","article-title":"A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease","volume":"7","author":"Hofgaard","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2020062311293582000_B18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/leu.2015.278","article-title":"Idiotype-specific CD4(+) T cells eradicate disseminated myeloma","volume":"30","author":"Haabeth","year":"2016","journal-title":"Leukemia"},{"issue":"6","key":"2020062311293582000_B19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-3083.2011.02558.x","article-title":"Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells? Implications for cancer immunotherapy by adoptive T cell transfer","volume":"73","author":"Corthay","year":"2011","journal-title":"Scand J Immunol"},{"issue":"14","key":"2020062311293582000_B20","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/0008-5472.CAN-08-4816","article-title":"Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells","volume":"69","author":"Corthay","year":"2009","journal-title":"Cancer Res"},{"issue":"16","key":"2020062311293582000_B21","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1158\/0008-5472.CAN-14-3640","article-title":"Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens","volume":"75","author":"Tveita","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"2020062311293582000_B22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncomms1239","article-title":"Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer","volume":"2","author":"Haabeth","year":"2011","journal-title":"Nat Commun"},{"issue":"12","key":"2020062311293582000_B23","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1073\/pnas.91.12.5700","article-title":"Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors","volume":"91","author":"Lauritzsen","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6972","key":"2020062311293582000_B24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"2020062311293582000_B25","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2011-10-388892","article-title":"Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice","volume":"119","author":"Lorvik","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2020062311293582000_B26","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/eji.1830201030","article-title":"A stimulatory monoclonal antibody detecting T cell receptor diversity among idiotype-specific, major histocompatibility complex-restricted T cell clones","volume":"20","author":"Bogen","year":"1990","journal-title":"Eur J Immunol"},{"issue":"11","key":"2020062311293582000_B27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1084\/jem.20020170","article-title":"Essential and instructive roles of GATA factors in eosinophil development","volume":"195","author":"Hirasawa","year":"2002","journal-title":"J Exp Med"},{"issue":"5813","key":"2020062311293582000_B28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/291334a0","article-title":"In vivo effect of anti-asialo GM1 antibody on natural killer activity","volume":"291","author":"Kasai","year":"1981","journal-title":"Nature"},{"issue":"4","key":"2020062311293582000_B29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1084\/jem.160.4.1114","article-title":"Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation","volume":"160","author":"Mercurio","year":"1984","journal-title":"J Exp Med"},{"issue":"1","key":"2020062311293582000_B30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1189\/jlb.0407247","article-title":"Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice","volume":"83","author":"Daley","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"7","key":"2020062311293582000_B31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/2159-8290.CD-18-1393","article-title":"Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents","volume":"9","author":"Lossos","year":"2019","journal-title":"Cancer Discov"},{"issue":"11","key":"2020062311293582000_B32","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00262-019-02374-0","article-title":"CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models","volume":"68","author":"Bogen","year":"2019","journal-title":"Cancer Immunol Immunother"},{"issue":"16","key":"2020062311293582000_B33","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1158\/0008-5472.CAN-17-2426","article-title":"CD4+ T-cell-Mediated Rejection of MHC Class II-Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs","volume":"78","author":"Haabeth","year":"2018","journal-title":"Cancer Res"},{"issue":"9","key":"2020062311293582000_B34","doi-asserted-by":"crossref","first-page":"e954953","DOI":"10.4161\/21624011.2014.954953","article-title":"Limitations of bystander killing in Th1\/M1 immune responses against a secreted tumor antigen","volume":"3","author":"Tveita","year":"2014","journal-title":"OncoImmunology"},{"issue":"7","key":"2020062311293582000_B35","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4161\/onci.21542","article-title":"A model for cancer-suppressive inflammation","volume":"1","author":"Haabeth","year":"2012","journal-title":"OncoImmunology"},{"issue":"2","key":"2020062311293582000_B36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","article-title":"Distinct role of macrophages in different tumor microenvironments","volume":"66","author":"Lewis","year":"2006","journal-title":"Cancer Res"},{"key":"2020062311293582000_B37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fimmu.2014.00174","article-title":"How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?","volume":"5","author":"Haabeth","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"2020062311293582000_B38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.154.3.713","article-title":"Expression of the macrophage-specific antigen F4\/80 during differentiation of mouse bone marrow cells in culture","volume":"154","author":"Hirsch","year":"1981","journal-title":"J Exp Med"},{"issue":"4","key":"2020062311293582000_B39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/1074-7613(95)90176-0","article-title":"Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells","volume":"3","author":"Wang","year":"1995","journal-title":"Immunity"},{"key":"2020062311293582000_B40","doi-asserted-by":"crossref","first-page":"183602","DOI":"10.1155\/2013\/183602","article-title":"Multiple myeloma macrophages: pivotal players in the tumor microenvironment","volume":"2013","author":"Berardi","year":"2013","journal-title":"J Oncol"},{"issue":"3","key":"2020062311293582000_B41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4049\/jimmunol.1100889","article-title":"M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells","volume":"187","author":"Heusinkveld","year":"2011","journal-title":"J Immunol"},{"issue":"4820","key":"2020062311293582000_B42","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/1931086a0","article-title":"Induction of plasma-cell neoplasms in strain BALB\/c mice with mineral oil and mineral oil adjuvants","volume":"193","author":"Potter","year":"1962","journal-title":"Nature"},{"issue":"17","key":"2020062311293582000_B43","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1182\/blood-2009-05-220285","article-title":"Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis","volume":"114","author":"Zheng","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2020062311293582000_B44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2012.09154.x","article-title":"Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells","volume":"158","author":"Kim","year":"2012","journal-title":"Br J Haematol"},{"issue":"68","key":"2020062311293582000_B45","doi-asserted-by":"crossref","first-page":"112685","DOI":"10.18632\/oncotarget.22340","article-title":"Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"2020062311293582000_B46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00277-012-1652-6","article-title":"Tumor-associated macrophages as a prognostic parameter in multiple myeloma","volume":"92","author":"Suyan\u0131","year":"2013","journal-title":"Ann Hematol"},{"issue":"4","key":"2020062311293582000_B47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2015.191","article-title":"Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma","volume":"30","author":"Panchabhai","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"2020062311293582000_B48","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/eji.201444659","article-title":"Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells","volume":"44","author":"Tveita","year":"2014","journal-title":"Eur J Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2595\/1745774\/advancesadv2020001434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2595\/1745774\/advancesadv2020001434.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T15:30:12Z","timestamp":1592926212000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/12\/2595\/460925\/CD4-Tcell-killing-of-multiple-myeloma-cells-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001434","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]}}}